scholarly journals Different Types of Minor Blood Group Incompatibility Causing Haemolytic Disease of Neonates in one of the National Children’s Medical Centre in China

2021 ◽  
Vol Volume 12 ◽  
pp. 497-504
Author(s):  
Mingchun Lin ◽  
Meixiu Liu ◽  
Shulian Zhang ◽  
Chao Chen ◽  
Jin Wang
Keyword(s):  
Blood Group ◽  
Medical Centre ◽  
Haemolytic Disease ◽  
Different Types

Relationship Between ABO Blood Group and Renal Disease Patients Attending Dee Medical Centre, Bukuru, Jos, Plateau State, Nigeria

2020 ◽  
Vol 14 (1) ◽  
pp. 1-5
Author(s):  
E.C. Onuoha ◽  
E.M. Ike ◽  
B.O. Eledo ◽  
F.E. Hallie ◽  
T.A. Diepreye ◽  
...  
Keyword(s):  
Renal Disease ◽  
Blood Group ◽  
Medical Centre ◽  
Abo Blood Group ◽  
Jos Plateau ◽  
Plateau State

‘Heibel’ a New Rare Human Blood Group Antigen, Revealed by a Haemolytic Disease of a Newborn

Vox Sanguinis ◽  
1968 ◽  
Vol 14 (4) ◽  
pp. 307-309 ◽  
Author(s):  
L. Ballowitz ◽  
H. Fiedler ◽  
Ch. Hoffmann ◽  
H. Pettenkofer
Keyword(s):  
Blood Group ◽  
Human Blood ◽  
Blood Group Antigen ◽  
Haemolytic Disease ◽  
Human Blood Group

scholarly journals Haemolytic Disease of Newborn due to Minor Blood Group C IncompatibilityA Case Report

2019 ◽  
Vol 8 (36) ◽  
pp. 2826-2827
Author(s):  
Kelawala Pooja M. ◽  
Mangal Dhananjay ◽  
Singh Sourabh ◽  
Singhal Chanchal
Keyword(s):  
Case Report ◽  
Blood Group ◽  
Haemolytic Disease

scholarly journals Blood Group O Positive is Susceptible for Different Types of Malignancy

KYAMC Journal ◽  
2019 ◽  
Vol 10 (3) ◽  
pp. 133-136
Author(s):  
Ayesha Yasmin ◽  
Md Nazmul Alam ◽  
Md Ershadul Haque ◽  
Kamrunnahar Alo ◽  
Badar Uddin ◽  
...  
Keyword(s):  
Risk Factors ◽  
Blood Group ◽  
Genetic Risk ◽  
Blood Groups ◽  
Cancer Center ◽  
Age Group ◽  
Standard Methods ◽  
The World ◽  
Different Types ◽  
Negative Conclusion

Background: Blood group is one of the major genetic risk factors for developing different types of malignancy throughout the world. Objectives: To find out the susceptible blood group in ABO and Rhesus systems in patients with malignancy. Methods and Materials: This study was one at KYAMCH cancer center, Enayetpur, Sirajganj, from October 2018 to February 2019. Total 150 cancer patients attending OPD were included irrespective of age, sex, socioeconomic status. ABO and Rhesus blood groups were determined in laboratory by standard methods. Results: Among 150 patients, 55% were female and 45% were male. Malignancy was predominant in the age group of41-50 years (25.3%) and 33.33% patients were found to have O blood group. Out of the patients, 98.7% had Rh positive of all blood groups of which 32% was belonged to blood group O. Metastasis was found among 34.66% patients and out of this 14.67% were having O blood group. Among 22 metastatic O blood group patients, 90.9% was Rh positive and 9.09% was Rh negative. Conclusion: Various types of malignancy are common among O positive blood group. KYAMC Journal Vol. 10, No.-3, October 2019, Page 133-136

Prevalence of Diabetes Mellitus types 1 and 2 in Erbil City and related factors

2018 ◽  
Vol 2 (1) ◽  
Author(s):  
Galawezh Othman
Keyword(s):  
Diabetes Mellitus ◽  
Blood Group ◽  
Diabetic Patients ◽  
Related Factors ◽  
Family Strain ◽  
Different Types ◽  
The Relationship ◽  
Prevalence Of Diabetes Mellitus

This study aimed to investigate the prevalence of different types of Diabetes Mellitus; the data collected from 84 patients randomly in Layla Qasem Diabetic center in Erbil city to study some genetic factors on Diabetes Mellitus disease by depend on their ages, gender, family history, Blood group and albumin in urine. In case of age average of their age was 40% between 50_60 years old and by depending on their Gender, average of genders 70% was female and 30% male in type 2, while in type 1 40% female and 60% male. The relationship between their family strain 43% of them was positive in type 2DM, and 50% positive in type 1DM. Then we compared their blood group according to our results 39 % of them was O blood group,  and in case of albumin in their urine ,in type 2 DM 35% was 30mg/l ,37% was 10mg/l, 9% was 150mg/l, and  19% was 80 mg/l .also in type 1DM 43% was 10mg/l, 11% was 150mg/l, 33% was 30 mg/l, and  13% 80mg/l . We concluded that Diabetes Mellitus in our area is more common in female than male, the percentage of the diabetes increased with age and most diabetic patients have O blood Group.

scholarly journals Severe hemolytic disease of the premature newborn due to RH1 incompatibility: a case report

2016 ◽  
Vol 89 (4) ◽  
pp. 565-568 ◽  
Author(s):  
Jean Uwingabiye ◽  
Hafid Zahid ◽  
Fayçal Labrini ◽  
Abdelhak El Khazraji ◽  
Anass Yahyaoui ◽  
...  
Keyword(s):  
Blood Group ◽  
Serum Bilirubin ◽  
Serum Bilirubin Level ◽  
Total Serum ◽  
Hemolytic Disease ◽  
Close Collaboration ◽  
Haemolytic Disease ◽  
Total Serum Bilirubin Level ◽  
Antiglobulin Test ◽  
History Of

We report a case of dramatic outcome of severe haemolytic disease in a newborn due to RH1 incompatibility. A newborn with A RH1 blood group was admitted in the Mohammed V Military Teaching Hospital for the problem of hydrops fetalis associated with RH1 incompatibility. The blood group of his mother, aged 31, was AB RH1-negative and that of his 37 year old father was A RH1.The mother had a history of 4 term deliveries, 3 abortions, and 1 living child. There was no prevention by anti-D immunoglobulin postpartum. The mother‘s irregular agglutinin test was positive and the pregnancy was poorly monitored. The laboratory tests of the newborn showed a high total serum bilirubin level (30 mg/L) and macrocytic regenerative anemia (Hemoglobin=4 g/dL, mean corpuscular volume = 183 fL, reticulocytes count =176600/m3). The blood smear showed 1256 erythroblasts per 100 leukocytes, Howell–Jolly bodies and many macrocytes. The direct antiglobulin test was positive. He was transfused with red blood cell concentrates and treated with conventional phototherapy. The evolution was unfavourable; he died three days after the death of his mother. The monitoring of these high-risk pregnancies requires specialized centers and a close collaboration between the gynaecologist and the blood transfusion specialist to strengthen the prevention, as well as clinico-biological monitoring in patients with a history of RH1 fetomaternal alloimunization.

Sign in / Sign up

Export Citation Format

Share Document